Computer-Aided Design of Antimicrobial Peptides

Christopher D. Fjell, Robert E.W. Hancock, Håvard Jenssen

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

    Resumé

    An increasing number of reported cases of drug resistant Staphylococcus aureus and Pseudomonas aeruginosa, demonstrate the urgent need for new therapeutics that are effective against such and other multi-drug resistant bacteria. Antimicrobial peptides have for two decades now been looked upon as interesting leads for development of new therapeutics combating these drug resistant microbes.

    High-throughput screening of peptide libraries have generated large amounts of information on peptide activities. However, scientists still struggle with explaining the specific peptide motifs resulting in antimicrobial activity. Consequently, the majority of peptides put into clinical trials have failed at some point, underlining the importance of a thorough peptide optimization.

    An important tool in peptide design and optimization is quantitative structure-activity relationship (QSAR) analysis, correlating chemical parameters with biological activities of the peptide, using statistical methods. In this review we will discuss two different in silico strategies of computer-aided antibacterial peptide design, a linear correlation model build as an extension of traditional principal component analysis (PCA) and a non-linear artificial neural network model. Studies on structurally diverse peptides, have concluded that the PCA derived model are able to guide the antibacterial peptide design in a meaningful way, however requiring rather a high homology between the peptides in the test-set and the in silico library, to ensure a successful prediction. In contrast, the neural network model, though significantly less explored in relation to antimicrobial peptide design, has proven extremely promising, demonstrating impressive prediction success and ranking of random peptide libraries correlating well with measured activities
    OriginalsprogEngelsk
    TidsskriftCurrent Pharmaceutical Analysis
    Vol/bind6
    Udgave nummer2
    Sider (fra-til)66-75
    ISSN1573-4129
    DOI
    StatusUdgivet - 2010

    Citer dette

    Fjell, Christopher D. ; Hancock, Robert E.W. ; Jenssen, Håvard. / Computer-Aided Design of Antimicrobial Peptides. I: Current Pharmaceutical Analysis. 2010 ; Bind 6, Nr. 2. s. 66-75.
    @article{91e43e90df5f4cfdae4fc0f9d3cb8c34,
    title = "Computer-Aided Design of Antimicrobial Peptides",
    abstract = "An increasing number of reported cases of drug resistant Staphylococcus aureus and Pseudomonas aeruginosa, demonstrate the urgent need for new therapeutics that are effective against such and other multi-drug resistant bacteria. Antimicrobial peptides have for two decades now been looked upon as interesting leads for development of new therapeutics combating these drug resistant microbes. High-throughput screening of peptide libraries have generated large amounts of information on peptide activities. However, scientists still struggle with explaining the specific peptide motifs resulting in antimicrobial activity. Consequently, the majority of peptides put into clinical trials have failed at some point, underlining the importance of a thorough peptide optimization. An important tool in peptide design and optimization is quantitative structure-activity relationship (QSAR) analysis, correlating chemical parameters with biological activities of the peptide, using statistical methods. In this review we will discuss two different in silico strategies of computer-aided antibacterial peptide design, a linear correlation model build as an extension of traditional principal component analysis (PCA) and a non-linear artificial neural network model. Studies on structurally diverse peptides, have concluded that the PCA derived model are able to guide the antibacterial peptide design in a meaningful way, however requiring rather a high homology between the peptides in the test-set and the in silico library, to ensure a successful prediction. In contrast, the neural network model, though significantly less explored in relation to antimicrobial peptide design, has proven extremely promising, demonstrating impressive prediction success and ranking of random peptide libraries correlating well with measured activities",
    author = "Fjell, {Christopher D.} and Hancock, {Robert E.W.} and H{\aa}vard Jenssen",
    year = "2010",
    doi = "10.2174/157341210791202645",
    language = "English",
    volume = "6",
    pages = "66--75",
    journal = "Current Pharmaceutical Analysis",
    issn = "1573-4129",
    publisher = "Bentham Science Publishers Ltd.",
    number = "2",

    }

    Computer-Aided Design of Antimicrobial Peptides. / Fjell, Christopher D.; Hancock, Robert E.W.; Jenssen, Håvard.

    I: Current Pharmaceutical Analysis, Bind 6, Nr. 2, 2010, s. 66-75.

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

    TY - JOUR

    T1 - Computer-Aided Design of Antimicrobial Peptides

    AU - Fjell, Christopher D.

    AU - Hancock, Robert E.W.

    AU - Jenssen, Håvard

    PY - 2010

    Y1 - 2010

    N2 - An increasing number of reported cases of drug resistant Staphylococcus aureus and Pseudomonas aeruginosa, demonstrate the urgent need for new therapeutics that are effective against such and other multi-drug resistant bacteria. Antimicrobial peptides have for two decades now been looked upon as interesting leads for development of new therapeutics combating these drug resistant microbes. High-throughput screening of peptide libraries have generated large amounts of information on peptide activities. However, scientists still struggle with explaining the specific peptide motifs resulting in antimicrobial activity. Consequently, the majority of peptides put into clinical trials have failed at some point, underlining the importance of a thorough peptide optimization. An important tool in peptide design and optimization is quantitative structure-activity relationship (QSAR) analysis, correlating chemical parameters with biological activities of the peptide, using statistical methods. In this review we will discuss two different in silico strategies of computer-aided antibacterial peptide design, a linear correlation model build as an extension of traditional principal component analysis (PCA) and a non-linear artificial neural network model. Studies on structurally diverse peptides, have concluded that the PCA derived model are able to guide the antibacterial peptide design in a meaningful way, however requiring rather a high homology between the peptides in the test-set and the in silico library, to ensure a successful prediction. In contrast, the neural network model, though significantly less explored in relation to antimicrobial peptide design, has proven extremely promising, demonstrating impressive prediction success and ranking of random peptide libraries correlating well with measured activities

    AB - An increasing number of reported cases of drug resistant Staphylococcus aureus and Pseudomonas aeruginosa, demonstrate the urgent need for new therapeutics that are effective against such and other multi-drug resistant bacteria. Antimicrobial peptides have for two decades now been looked upon as interesting leads for development of new therapeutics combating these drug resistant microbes. High-throughput screening of peptide libraries have generated large amounts of information on peptide activities. However, scientists still struggle with explaining the specific peptide motifs resulting in antimicrobial activity. Consequently, the majority of peptides put into clinical trials have failed at some point, underlining the importance of a thorough peptide optimization. An important tool in peptide design and optimization is quantitative structure-activity relationship (QSAR) analysis, correlating chemical parameters with biological activities of the peptide, using statistical methods. In this review we will discuss two different in silico strategies of computer-aided antibacterial peptide design, a linear correlation model build as an extension of traditional principal component analysis (PCA) and a non-linear artificial neural network model. Studies on structurally diverse peptides, have concluded that the PCA derived model are able to guide the antibacterial peptide design in a meaningful way, however requiring rather a high homology between the peptides in the test-set and the in silico library, to ensure a successful prediction. In contrast, the neural network model, though significantly less explored in relation to antimicrobial peptide design, has proven extremely promising, demonstrating impressive prediction success and ranking of random peptide libraries correlating well with measured activities

    U2 - 10.2174/157341210791202645

    DO - 10.2174/157341210791202645

    M3 - Review

    VL - 6

    SP - 66

    EP - 75

    JO - Current Pharmaceutical Analysis

    JF - Current Pharmaceutical Analysis

    SN - 1573-4129

    IS - 2

    ER -